Clinical Trials Directory

Trials / Unknown

UnknownNCT04860037

Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients

Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients : What About Their Consequences ?

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The diagnosis and the follow-up of acromegalic patients are based on the mesurement of Growth hormone (GH) and IGF1 rates. However, the literature described some cases of patient for whom the investigators observed a discrepancy between GH and IGF1 rates. Since the acromegaly is a rare disease and this phenomenon concerns about 30% of these patients, there is a lack of investigations about consequences that this discordance may induces. In this study, the investigators aimed at assessing if patients with discordance between GH and IGF1 rates present a different risk of recurrence and complications related to acromegaly, from patients with concordant results.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2022-04-01
Completion
2022-12-01
First posted
2021-04-26
Last updated
2021-04-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04860037. Inclusion in this directory is not an endorsement.